Company: JUPGF
Filing Date: 2025-08-27
Form Type: DRS/A
Source: 0001493152-25-012379
Chunk: 204

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-08-27
Form: DRS/A
Chunk 204
---
 the corporation or any stockholder of the corporation for monetary
damages for breach of fiduciary duty as a director or officer, provided that a director or officer’s liability will not be limited
for any breach of the director’s or the officer’s duty of loyalty to the corporation or its stockholder, for acts or omissions
not in good faith or which involve intentional misconduct or a knowing violation of law or for any transaction from which the director
or officer derived an improper personal benefit.

Such limitation of liability and indemnification does
not affect the availability of equitable remedies. In addition, the registrant has been advised that in the opinion of the SEC, indemnification
for liabilities arising under the Securities Act is against public policy as expressed in the Securities Act and is therefore unenforceable.
The registrant has obtained directors’ and officers’ liability insurance against any liability asserted against such person
incurred in the capacity of director or officer or arising out of such status, whether or not the registrant would have the power to indemnify
such person.

Item 7. Recent Sales of Unregistered Securities.

In the three years preceding
the filing of this registration statement, we issued the securities described below without registration under the Securities Act. The
securities were issued pursuant to the private placement exemption provided by Section 4(a)(2) of the Securities Act. The list
below accounts for effects of the Reverse Stock Split.

In June 2023, the registrant
issued 32,070 shares of common stock to Atlas Lithium, in satisfaction of the acquisition of a gold processing plant for a total
consideration of $320,700.

In 2022, we issued to three
investors an aggregate of 185,353 unregistered shares of our common stock for $489,875.

In 2023, we issued to five
investors an aggregate of 50,648 unregistered shares of our common stock for $291,600.

In 2024, we issued to 14 to investors an aggregate
of 300,916 unregistered shares of our common stock for $1,582,250.

In connection with the foregoing, we relied upon the
exemption from registration provided by Section 4(a)(2) under the Securities Act, for transactions not involving a
public offering.

Item 8. Exhibits and Financial Statement Schedules.

| (a) | Exhibits: See Exhibit Index beginning on page II-4 of this registration statement.                                                                                                                                                                                                                                                         |